通过重新编程Hippo-YAP/TAZ信号通路的致癌转录,SRCAP复合物促进肺癌的进展
Huixia Zhang1, Shasha Li1, Runxin Zhou2
1Department of Human Anatomy, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan, 430030, China.
通过调节H2A.Z沉积,SRCAP复合物促进了YAP/TAZ驱动的癌症转录. 阻止SRCAP抑制瘤生长,为肺癌提供潜在的诊断和治疗点.
科学领域:
- 分子瘤学分子瘤学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症生物学 癌症生物学
背景情况:
- YAP/TAZ转录协活性剂是癌症进展的关键驱动因素.
- 在瘤中YAP/TAZ促进失调转录的确切机制尚不清楚.
研究的目的:
- 阐明YAP/TAZ驱动的瘤转录的分子机制.
- 确定YAP/TAZ介导癌症的新型治疗点.
主要方法:
- 用于YAP/TAZ互原子识别的生物标识.
- 协同免疫沉和免疫光用于相互作用验证.
- 对H2A.Z沉积的CUT&Tag分析.
- 对SRCAP复合物的遗传枯竭和药理学阻断.
- 在肺腺癌小鼠模型和患者样本中的分析.
主要成果:
- YAP/TAZ与SRCAP复合体相互作用,这促进了H2A.Z在目标促进体上的沉积.
- SRCAP复合物的耗尽减少了H2A.Z占用和瘤转录,抑制了YAP驱动的瘤生长.
- 在肺癌中,SRCAP复合物和H2A.Z被上调,与YAP表达和生存率低下相关.
结论:
- 通过H2A.Z沉积,SRCAP复合物对YAP/TAZ瘤转录至关重要.
- 对于YAP/TAZ驱动的癌症,SRCAP复合体是一个潜在的治疗标.
- SRCAP复合物和H2A.Z上调作为肺癌诊断和预后的潜在生物标志物.
更多相关视频
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
07:16Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Hedgehog Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Induced Pluripotent Stem Cells
Somatic...
